Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Baicalin capsule formula and production process of baicalin capsule

A baicalin capsule and a production process technology, applied in the field of medicine, can solve problems such as poor stability and low bioavailability, and achieve the effects of improved drug efficacy, good adaptability, guaranteed drug efficacy and ease of use

Inactive Publication Date: 2017-07-14
东莞市金美济药业有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Existing baicalin oral liquid preparations have problems such as poor stability and low bioavailability

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Baicalin capsule formula and production process of baicalin capsule

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0031] The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

[0032] see figure 1 , a formula of baicalin capsules, comprising the following raw materials: baicalin, dissolving agent, diluent, emulsification solubilizing and anti-oxidation stabilizer and sunscreen, wherein the amount of baicalin is 32-78% of the formula amount, dissolving agent and The diluent is mainly animal and vegetable oils, which can be used alone or mixed according to different proportions. By increasing the solubility of baicalin in animal and ve...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a baicalin capsule formula and a production process of a baicalin capsule. The baicalin capsule is mainly prepared from baicalin, a dissolving agent, a diluting agent, an emulsifying-solubilizing agent, an antioxidant stabilizer and a light-screening agent, wherein the using amount of the baicalin is 32 to 78 percent of the prescription dosage; the dissolving agent and the diluting agent are mainly animal oil and plant oil; the baicalin stability can be improved effectively by increasing the solubility of the baicalin in the animal oil and the plant oil; the antioxidant stabilizer is vitamin E and ascorbic acid ester palmitate in order to enhance the oxidation resistance of a product; a soft capsule shell is made of gelatin, glycerol and sorbitol, and the light-screening agent is added; the materials are dissolved and mixed uniformly by blanching, stirring and heating, and then pressing, molding and drying are performed to obtain the baicalin capsule. By adopting the baicalin capsule, the problems of low stability, low bioavailability and the like in a baicalin oral liquid preparation are solved; the baicalin capsule with aqueous content is prepared, so that the medicinal effect is brought into full play, and the price is lowered.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a formula of baicalin capsules and a production process thereof. Background technique [0002] Clinical practice has proved that the main links in the treatment of chronic hepatitis B are anti-virus, protection of liver cells, regulation of immunity and prevention of fibrosis, and the key issue is anti-virus. [0003] Scutellaria baicalensis is the root of Scutellaria baicalensis, a plant of the Labiatae family. Clinically, scutellaria baicalensis has the functions of clearing away heat, purging fire, detoxifying, hemostasis, and preventing miscarriage, and has a wide range of pharmacological effects. In recent years, in-depth research has been carried out on the components, pharmacology, and efficacy of Scutellaria baicalensis at home and abroad, and its active ingredient, flavonoid compound baicalin, has been found. Pharmacological studies on the active ingredients in Scutell...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/48A61K31/7048A61K47/42A61P1/16A61P31/20
CPCA61K9/4883A61K9/4808A61K9/4825A61K9/4858A61K31/7048
Inventor 杨小兵
Owner 东莞市金美济药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products